New Zealand Official CrestGazette.govt.nz
Advanced search
Find a specific notice:
Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Tasigna
Nilotinib hydrochloride monohydrate 165.45mg
equivalent to nilotinib anhydrous free base 150mg
Capsule
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Active Ingredient:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Tasigna
Nilotinib hydrochloride monohydrate 220.6mg
equivalent to nilotinib anhydrous free base 200mg
Capsule
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland

Dated this 17th day of August 2018.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Publication Date
23 Aug 2018

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2018-go4104
Title
View PDF
Description
File Type and Size
PDF (28 KB)
Page Number 0